You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 14, 2025

Details for Patent: 10,555,925


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,555,925 protect, and when does it expire?

Patent 10,555,925 protects VASCEPA and is included in one NDA.

This patent has eighty patent family members in forty-one countries.

Summary for Patent: 10,555,925
Title:Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular disease
Abstract: In various embodiments, the present invention provides methods of reducing the risk of a cardiovascular event in a subject on statin therapy and, in particular, a method of reducing the risk of a cardiovascular event in a subject on statin therapy having a fasting baseline triglyceride level of about 135 mg/dL to about 500 mg/dL, and administering to the subject a pharmaceutical composition comprising about 1 g to about 4 g of eicosapentaenoic acid ethyl ester or a derivative thereof.
Inventor(s): Soni; Paresh (Mystic, CT)
Assignee: Amarin Pharmaceuticals Ireland Limited (IE)
Application Number:16/599,412
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,555,925

Introduction

United States Patent 10,555,925, titled "Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular disease," is a patent that outlines innovative methods for mitigating cardiovascular risks. To understand the full implications and protective scope of this patent, it is crucial to delve into its claims, scope, and the broader patent landscape.

Understanding the Patent

Publication Details

  • Publication Number: US10555925B1
  • Authority: United States
  • Prior Art Date: This information is not explicitly provided in the source, but it is essential to note that prior art dates are critical in determining the novelty and non-obviousness of the invention[4].

Summary of the Invention

The patent describes methods aimed at reducing the risk of cardiovascular events in subjects who are already on statin therapy. These methods involve specific treatments and monitoring protocols designed to enhance the efficacy of statin therapy and minimize cardiovascular risks.

Claims Analysis

Types of Claims

Patent claims are the heart of any patent application, defining the scope of protection. For US10555925B1, the claims can be categorized into:

  • Independent Claims: These claims stand alone and define the broadest scope of the invention.
  • Dependent Claims: These claims build upon the independent claims and provide more specific details, often narrowing the scope.

Claim Structure

  • Claim 1: Typically the broadest independent claim, it sets the foundation for the invention.
    • For example, Claim 1 might describe the general method of reducing cardiovascular risk using a specific treatment protocol.
  • Subsequent Claims: These claims may include additional steps, specific dosages, or particular patient groups, further defining the invention.

Scope Concepts

To analyze the claims effectively, it is helpful to categorize them by scope concepts, as suggested by patent analytics practices. This involves grouping claims based on overarching themes or technologies they cover. For US10555925B1, scope concepts might include:

  • Treatment Protocols: Claims related to the specific methods of treatment.
  • Patient Groups: Claims related to the types of patients who can benefit from the treatment.
  • Monitoring and Follow-Up: Claims related to the procedures for monitoring and adjusting the treatment[3].

Patent Landscape Analysis

Competing Patents

To understand the competitive landscape, it is essential to identify other patents that may cover similar technologies or methods. This can be done using tools like the USPTO's Patent Public Search or international databases such as the European Patent Office's esp@cenet or the World Intellectual Property Organization's PATENTSCOPE[1].

Prior Art and Citations

The Common Citation Document (CCD) application can be useful here, as it consolidates prior art citations from multiple patent offices, helping to identify potential overlaps or gaps in the patent landscape[1].

Global Patent Family

Using the Global Dossier service, one can view the patent family for US10555925B1, including related applications filed at participating IP offices. This helps in understanding the global reach and protection of the invention[1].

Claim Coverage Matrix

A Claim Coverage Matrix is a valuable tool for visualizing which patents and claims are actively protecting the intellectual property related to US10555925B1. This matrix can help identify:

  • Gaps in Coverage: Areas where the current claims do not provide adequate protection.
  • Future Design Opportunities: Potential areas for future innovation and patent filings[3].

Interactive Claim Charts

Using tools like ClaimScape® software, interactive claim charts can be generated to help technical experts, engineers, and management review the patent coverage. These charts can be updated as new patents are filed or as development avenues are explored, ensuring that the patent landscape remains aligned with business strategies[3].

Legal and Regulatory Considerations

Patent Validity and Enforcement

Ensuring the validity and enforceability of the patent is crucial. This involves regular monitoring of office actions and any legal challenges. The Patent Examination Data System (PEDS) and the Patent Assignment Search can provide valuable insights into the patent's status and ownership changes[1].

Potential for Small Claims Court

In the event of disputes or infringement claims, understanding the feasibility of a small claims patent court, as studied by the Administrative Conference of the United States (ACUS), could provide a more streamlined and cost-effective resolution process[2].

Key Takeaways

  • Claims Analysis: Understanding the structure and scope of the claims is essential for determining the protective scope of the patent.
  • Patent Landscape: Analyzing competing patents and prior art helps in identifying gaps and opportunities.
  • Global Reach: Using tools like Global Dossier to view the patent family can provide insights into global protection.
  • Claim Coverage Matrix: This tool helps in visualizing the coverage and identifying gaps.
  • Legal Considerations: Monitoring patent validity and understanding legal options like small claims courts are vital.

FAQs

Q: What is the primary focus of United States Patent 10,555,925? A: The primary focus is on methods for reducing the risk of cardiovascular events in subjects at risk for cardiovascular disease, particularly those on statin therapy.

Q: How can one analyze the claims of a patent effectively? A: By categorizing claims into scope concepts, using tools like Claim Coverage Matrix, and generating interactive claim charts.

Q: What is the Global Dossier service, and how is it useful? A: The Global Dossier service provides access to the file histories of related applications from participating IP offices, helping to view the patent family and understand global protection.

Q: How can one identify gaps in patent coverage? A: Using a Claim Coverage Matrix and interactive claim charts to visualize the current coverage and identify areas where additional protection may be needed.

Q: What is the significance of the Common Citation Document (CCD) application? A: The CCD application consolidates prior art citations from multiple patent offices, enabling the visualization of search results for the same invention on a single page.

Sources

  1. USPTO - Search for patents
  2. ACUS - U.S. Patent Small Claims Court
  3. SLWIP - Patent Analytics
  4. Google Patents - US10555925B1

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,555,925

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Amarin Pharms VASCEPA icosapent ethyl CAPSULE;ORAL 202057-001 Jul 26, 2012 AB RX Yes Yes 10,555,925 ⤷  Try for Free USE OF VASCEPA AS AN ADJUNCT TO STATIN THERAPY TO REDUCE THE RISK OF STROKE IN AN ADULT PATIENT WITH ESTABLISHED CARDIOVASCULAR DISEASE ⤷  Try for Free
Amarin Pharms VASCEPA icosapent ethyl CAPSULE;ORAL 202057-002 Feb 16, 2017 AB RX Yes No 10,555,925 ⤷  Try for Free USE OF VASCEPA AS AN ADJUNCT TO STATIN THERAPY TO REDUCE THE RISK OF STROKE IN AN ADULT PATIENT WITH ESTABLISHED CARDIOVASCULAR DISEASE ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.